Let's Go1. Study in 3,592 people with type 2 diabetes aged 18 and older comparing baseline therapy to 3 months of Omnipod or Omnipod DASH use. Average A1c at baseline vs. 3-months of Omnipod = 9.2 vs. 7.9%. Average TDD at baseline vs. 3-months of Omnipod = 103 vs. 71. Aver...
The Program is open to new Pod Therapy patients coming from multiple daily injections or tubed pumps only who have not previously used Omnipod 5, Omnipod DASH® or Omnipod Insulin Management System. This offer is not valid for participants whose Omnipod 5 or compatible CGM prescription is ...